Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Jon Kindblom

Physician

Jon Kindblom
Physician
MD, PhD
jon.kindblom@medic.gu.se
+46 31-342 1000

Postal Address: Jubileumskliniken, Sahlgrenska universitetssjukhuset, 413 45 Göteborg
Visiting Address: Jubileumskliniken, Sahlgrenska universitetssjukhuset, Blå stråket 2 , Göteborg


Department of Oncology at Institute of Clinical Sciences (More Information)
Sahlgrenska Universitetssjukhuset
413 45 Göteborg
0313428503
Visiting Address: Blå stråket 2 SU/Jubileusklin , 413 45 Göteborg

Latest publications

Extreme Hypofractionation versus Conventionally Fractionated Radiotherapy for Intermediate Risk Prostate Cancer: Early Toxicity Results from the Scandinavian Randomized Phase III Trial “HYPO-RT-PC”
A. Widmark, A. Gunnlaugsson, L. Beckman, C. Thellenberg-Karlsson, M. Hoyer et al.
International Journal of Radiation Oncology, Biology, Physics, 96 (5), s. 938–939, Conference paper 2016
Conference paper

Alpha emitter radium-223 and survival in metastatic prostate cancer.
C Parker, S Nilsson, D Heinrich, S I Helle, J M O'Sullivan et al.
The New England journal of medicine, Journal article 2013
Journal article

Targeting stromal androgen receptor suppresses prolactin-driven benign prostatic hyperplasia (BPH).
Kuo-Pao Lai, Chiung-Kuei Huang, Lei-Ya Fang, Kouji Izumi, Chi-Wen Lo et al.
Molecular endocrinology (Baltimore, Md.), Journal article 2013
Journal article

Effective oral combination metronomic chemotherapy with low toxicity for the management of castration-resistant prostate cancer.
Åsa Jellvert, Ingela Frank-Lissbrant, Maliha Edgren, Elisabeth Ovferholm, Karin Braide et al.
Experimental and therapeutic medicine, Journal article 2011
Journal article

Showing 1 - 10 of 16

2019

2016

Extreme Hypofractionation versus Conventionally Fractionated Radiotherapy for Intermediate Risk Prostate Cancer: Early Toxicity Results from the Scandinavian Randomized Phase III Trial “HYPO-RT-PC”
A. Widmark, A. Gunnlaugsson, L. Beckman, C. Thellenberg-Karlsson, M. Hoyer et al.
International Journal of Radiation Oncology, Biology, Physics, 96 (5), s. 938–939, Conference paper 2016
Conference paper

2014

2013

Alpha emitter radium-223 and survival in metastatic prostate cancer.
C Parker, S Nilsson, D Heinrich, S I Helle, J M O'Sullivan et al.
The New England journal of medicine, Journal article 2013
Journal article

Targeting stromal androgen receptor suppresses prolactin-driven benign prostatic hyperplasia (BPH).
Kuo-Pao Lai, Chiung-Kuei Huang, Lei-Ya Fang, Kouji Izumi, Chi-Wen Lo et al.
Molecular endocrinology (Baltimore, Md.), Journal article 2013
Journal article

2011

Effective oral combination metronomic chemotherapy with low toxicity for the management of castration-resistant prostate cancer.
Åsa Jellvert, Ingela Frank-Lissbrant, Maliha Edgren, Elisabeth Ovferholm, Karin Braide et al.
Experimental and therapeutic medicine, Journal article 2011
Journal article

Showing 1 - 10 of 16

Page Manager: Katarina Olinder Eriksson|Last update: 3/28/2013
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?

Denna text är utskriven från följande webbsida:
http://oncology.gu.se/Department+of+Oncology/staff/?languageId=100001&userId=xkinjo&userName=Jon+Kindblom
Utskriftsdatum: 2019-09-17